Back to Search
ENKHTSETSEG PUREV, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1952662249Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
D0073449(MD)
Research & Publications (19)
c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes.
PMID 19641021·Mol Biol Cell·2009
8-other
Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl.
PMID 17094785·FEBS J·2006
8-other
Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid.
PMID 16936753·Oncogene·2006
6-review
High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
PMID 16885338·Cancer Res·2006
7-preclinical
Interaction of PP2A catalytic subunit with Rb2/p130 is required for all-trans retinoic acid suppression of ovarian carcinoma cell growth.
PMID 16206244·J Cell Physiol·2006
8-other
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.
PMID 16034560·Cancer Immunol Immunother·2006
8-other
Abdominal aortic aneurysm is a specific antigen-driven T cell disease.
PMID 17182939·Ann N Y Acad Sci·2006
8-other
Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.
PMID 16038891·Cell Immunol·2005
8-other
Effect of all-trans retinoic acid on telomerase activity in ovarian cancer cells.
PMID 15354417·J Exp Clin Cancer Res·2004
8-other
Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R).
PMID 15528389·J Immunol·2004
7-preclinical
Colon cancer antigen and anti-idiotype vaccines.
PMID 15338751·Cancer Chemother Biol Response Modif·2003
8-other
Protein phosphatase 2A associates with Rb2/p130 and mediates retinoic acid-induced growth suppression of ovarian carcinoma cells.
PMID 12915404·J Biol Chem·2003
8-other
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside.
PMID 12649743·Cancer Immunol Immunother·2003
7-preclinical
Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients.
PMID 12639481·Vaccine·2003
8-other
Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
PMID 11768621·J Cancer Res Clin Oncol·2001
7-preclinical
Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
PMID 11279610·Int J Cancer·2001
3-trial
Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
PMID 11145641·J Immunol·2001
7-preclinical
Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector.
PMID 10911917·Ann N Y Acad Sci·2000
7-preclinical
Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis.
PMID 10900352·J Neuroimmunol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1952662249
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile